Aspire Capital Fund LLC 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-02 06:19 am Purchase | 2020-06-30 | 13G | Mereo BioPharma Group plc MREO | Aspire Capital Fund LLC | 20,680,882 6.110% | 20,680,882 (New Position) | Filing |